All clinical trial information current as of 5/17/19.
Please note that trial status and parameters may change at any time; please contact a trial site or investigator for the latest information on a given trial.
Amgen’s product pipeline will change over time as molecules move through the drug development process, including processing to market or failing in clinical trials, due to the nature of the development process. The descriptions herein contain forward-looking statements that involve significant risks and uncertainties, including those discussed in Amgen’s most recent Form 10-K and in Amgen’s periodic reports on Form 10-Q and Form 8-K, and actual results may vary materially. Amgen is providing this information as of the date above and does undertake any obligation to update any forward-looking statements contained in this table as a result of new information, future events or otherwise.